Business Wire

Seoul Semiconductor Europe Introduces Reference Modules for Its Wicop LEDs

Del

Seoul Semiconductor Europe, a subsidiary of Seoul Semiconductor Co.,Ltd, a world leader in LED-technology, today announced the availability of reference modules based on its package-free Wicop LEDs.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170302005217/en/

Seoul Semiconductor Europe Reference modules based on  Wicop LED technology (Photo: Business Wire)

Seoul Semiconductor Europe Reference modules based on Wicop LED technology (Photo: Business Wire)

“We found that offering module solutions, based on our highly innovative technologies, will allow our customers to evaluate the technology and its benefits easily, enabling them to realize their solutions faster than by just using LED components”, Mr. Andreas Weisl, CEO Seoul Semiconductor Europe and Vice President Sales, explains. “Resources at our customers are often limited, so they need powerful, reliable and easy to handle solutions to meet their requirements. As a solution provider, we help them to be ahead of competition and to achieve a fast time-to-market, also by creating customized modules in our Munich-based lab, we are able to offer”, he adds.

This first release includes reference modules for the Wicop Y19, Y22 and Y22P LEDs. The Y19 module consists of four clusters of 2 x 2 LEDs with a combined typical flux of 4,650 lumens, while the Y22 and Y22P modules achieve 1,268 lumens with four single LEDs each. They all feature a Color Rendering Index (CRI) of 70 and a Correlated Color Temperature (CCT) of 4,000 K.

All modules announced today are tailored to common customer needs and follow the outlines given in book 15 of the Zhaga specification, which defines the location and pitch of the LEDs and the position and size of the alignment holes for optical lenses. The boards feature standard power connectors and are easy to assemble and easy to use together with commercially available lenses, like the new Wilma lens-array from LEDiL.

Wicop LEDs with their luminous efficiency of up to 210 lm/W at 350 mA are well suited as light-source for applications for example such as wall washers or floodlights in the architectural space and lighting in warehouses or production sites in the industrial area. Outdoor they can be used for example for street lighting, in tunnels or for the illumination of stadiums, harbors, airports or railway stations, as well as for security applications.

Their compact footprint makes these LEDs several times smaller and much brighter than conventional LEDs, enabling cost savings at the system level. This is achieved through its state of the art chip design with the phosphor film directly attached to the chip surface, making the previously needed packaging with frames and gold wires obsolete. This way, Wicop LEDs are also suitable for applications, where a small form factor is needed.

The three reference modules introduced today are available from Seoul Semiconductor Europe. Production quantities can be provided on request. If necessary, they can also be customized by Seoul Semiconductor’s regional labs for special requirements.

# Reference

To learn more about Seoul Semiconductor’s Wicop LED-family:
http://www.seoulsemicon.com/WICOP/WICOP_en.asp

# Additional quote to be used

Marc Juarez, Head of Technical Team at Seoul Semiconductor Europe: “With these new modules, our customers can implement even faster our robust and efficient Wicop LEDs, which provide a market leading color uniformity combined with a high luminous efficiency. In addition, Seoul Semiconductor realized a very efficient process of delivering customized solutions, providing customers with the speed and flexibility needed in this rapidly changing environment.”

# About Seoul Semiconductor:

Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting and backlighting markets. As the fifth largest LED manufacturers globally, Seoul Semiconductor holds more than 10,000 patents, offers a wide range of technologies and high volume production of innovative LED products such as "Wicop" – Simpler Structured Package-Free LED, "Acrich” – the world's leading direct AC LED, "Acrich MJT – Multi-Junction-Technology" a proprietary family of high-voltage LEDs, and “nPola”, a new LED product based on GaN-substrate technology for over ten times output of conventional LEDs.

# Trademarks

WICOP is a trademark of Seoul Semiconductor Co., Ltd.

Contact information

Seoul Semiconductor PR Europe
Ariane Heim
Phone: +49(0)894503690-0
Email: press.eu@seoulsemicon.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom